← Back to Search

Combination Product

VCTX210A unit for Type 1 Diabetes

Phase 1
Waitlist Available
Research Sponsored by CRISPR Therapeutics AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment for people with Type 1 Diabetes. The treatment uses special cells that can become insulin-producing cells and a device to hold these cells in the body. The cells are modified to avoid being attacked by the immune system and to survive longer.

Eligible Conditions
  • Type 1 Diabetes
  • Diabetes
  • Autoimmune Disease
  • Immune Disorders
  • Endocrine Disorder
  • Metabolic Diseases
  • Endocrine Disorders
  • Autoimmune Diseases
  • Immune System Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VCTX210A combination productExperimental Treatment1 Intervention
Up to seven (7) units will be implanted
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VCTX210A unit
2022
Completed Phase 1
~10

Find a Location

Who is running the clinical trial?

ViaCyteIndustry Sponsor
6 Previous Clinical Trials
193 Total Patients Enrolled
CRISPR Therapeutics AGLead Sponsor
8 Previous Clinical Trials
885 Total Patients Enrolled
Sandeep Soni, MDStudy DirectorCRISPR Therapeutics
5 Previous Clinical Trials
66 Total Patients Enrolled
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top